Eribulin Mesylate 39822-2080-01

Package NDC

39822-2080-01

Product NDC: 39822-2080

Manufacturer: Xgen Pharmaceuticals Djb, Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 7, 2026
Listing Expires: December 31, 2027
Application: ANDA219054

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

39822-2080-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (39822-2080-1) / 2 mL in 1 VIAL, SINGLE-DOSE